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Alopecia areata is a common dis¢guring hair loss disor-
der that primarily a¡ects the hair follicle as it enters the
prolonged growth phase called anagen. The last few
years have yielded an explosion of more rigorously
obtained data on the etiology and pathogenesis of this
disorder. While a consensus is rapidly building in sup-
port of an autoimmune pathogenesis, there are still sev-
eral enigmatic issues to be resolved. These include the
possibility that alopecia areata is really a multientity
disorder with causes that are multifactorial. This will
have important implications for the research scientist’s
search for the jigsaw puzzle’s largest missing piece
the identi¢cation of the target autoantigen(s). There is
now much evidence that autoimmune diseases with
both T and B cell components have shared target auto-
antigens/epitopes. It is likely that alopecia areata is
similar, as there is now very strong evidence for the
generation of autoantibodies as well as autoreactive T
cells to hair follicles in the pathogenesis of this disease.
The following brief review outlines the progress we
have made over the last ¢ve to ten years in the charac-
terization of hair follicle antigens targeted by antibodies
in alopecia areata. Results of these studies now show
that the elicitation of antibodies to hair follicle^speci¢c
proteins is a highly conserved phenomenon in all af-
fected species studied to date. Candidate autoantigens
that have been identi¢ed include the 44/46 kDa hair-
speci¢c keratin (expressed in the precortical zone of
anagen hair follicles) and trichohyalin (an important
intermediate ¢lament^associated protein) expressed
in the inner root sheath of the growing hair follicle.
Moreover, there is evidence that anti-hair follicle
antibodies are modulated during the disease process,
can occur before clinically detectable hair loss,
and may be reduced in titer during successful treat-
ment. Preliminary data from passive transfer experi-
ments suggest that in some species these antibodies
may disrupt hair cycling. We are currently applying a
more molecular approach (e.g., cDNA library screening)
to identify hair follicle antigens truly associated
with the onset of the disorder. Keywords: autoimmunity
immunoglobulin G/trichohyalin keratins/immuno£uorescence.
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A
lopecia areata (AA) is a common cause of hair loss
a¥icting approximately 1%^2% of the general po-
pulation (Safavi et al, 1995). It has recently become
clear that this disorder is also expressed in several
nonhuman mammals (McElwee et al, 1998a), includ-
ing horses (Tobin et al, 1998a) and dogs (Olivry et al, 1996) as well
as inbred mice (Sundberg et al, 1994) and rats (Michie et al, 1991).
The incidence in humans and other mammals may be even high-
er as minor forms of the disorder may not be detected by the
patient/owner and so go unreported to the practitioner. AA is
commonly manifested by patchy areas of complete hair loss on
the scalp and other body parts, but can progress to complete loss
of all body hair. It results from selective, largely reversible damage
to anagen hair follicles (HF) (Tobin, 1997a) and, while not life
threatening, is nonetheless serious because of associated dis¢gure-
ment. In humans, AA can cause severe psychological and social
problems, including loss of employment; in animals, it can ser-
iously reduce an a¡ected animal’s commercial value.
The etiology of AA is still rather vague. Most researchers
agree, however, on the basis of several indirect and direct obser-
vations (reviewed in McDonagh and Messenger, 1996; McElwee
et al, 1999; Tobin and Bystryn, 2000), that an immune-mediated
pathogenesis is involved. Several of the requirements for ascrib-
ing autoimmune status (Rose, 1991) to AA now appear to be in
place. Not only can the disease be passively transferred byT cells
(Gilhar et al, 1998), but serum IgG may also disturb hair cycling
(Tobin et al, 1998a). Moreover, it appears that the immune
response to HF produces, rather than follows, the disease process
(McElwee et al, 1996a; Gilhar et al, 1998). Other indirect clues
for autoimmunity include the association of the disease with a
particular HLA haplotype(s), other autoimmune diseases, and
a responsitivity to immunosuppressive therapies (McElwee et al,
1999).
Casual perusal of the AA literature will quickly reveal that
much of the available data must be interpreted with extreme cau-
tion. Conclusions therein are often based on small numbers of
patients, on poorly controlled or uncontrolled studies, on di¡er-
ences whose signi¢cance has not been analyzed statistically,
and on results that are often contradictory. Part of this apparent
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confusion may be due to the likelihood that AA is a multientity
disorder, with causes that are multifactorial. Furthermore, there
was until very recently (Olsen et al, 1999) no universally accepted
criteria to describe the clinical manifestations for AA research.
Understanding the cause(s) of AA is important to discovering ef-
fective treatments and is of wider biological interest given that
AA may be part of a still poorly understood form of auto-aggres-
sion seen in other putative autoimmune skin diseases.
Others in this issue will discuss the immunobiology of the HF
and whether this skin appendage truly represents a rare example
of immune privilege. Also covered elsewhere in these workshop
proceedings is whether AA meets all the criteria for autoimmune
designation. For my part, I will review our current knowledge of
the abnormal antibody response to HF that occurs in humans and
in nonhuman mammals with AA. Special focus will be directed
to the remarkably conserved nature of the cellular and molecular
HF targets in AA of all species studied to date. Although there is
as yet no unequivocal evidence that autoantibodies to HF play an
active role in the onset, maintenance, or potentiation of AA,
there is every likelihood that autoantigen targets will be similar
for both the antibodies and the autoreactive T cells involved.
THE ‘‘AUTOIMMUNE’’ BASIS OFALOPECIA AREATA:
SOME BACKGROUND
Requirements for autoimmune designation for a disorder include
the demonstration of (i) unique antigen(s) in the a¡ected organ,
(ii) an autoimmune response (either antibody or T cell) to that
antigen(s), (iii) an autoimmune response speci¢cally associated
with the disease, (iv) an autoimmune response that produces
rather than follows the disease process, and (v) the passive transfer
of the disease by autoantibody or T cells. In the absence of some
of these, we may look for indirect clues for autoimmunity. These
may include the association of the disease with a particular HLA
haplotype, other autoimmune diseases, and a responsitivity to
immunosuppression therapies. It is important to stress, however,
that these are only clues and should not be taken alone as evi-
dence of an autoimmune etiology. For example, many in£amma-
tory nonautoimmune diseases bene¢t from immunosuppression.
The genetics of AA is still poorly understood. Frequency and
family histories in this disorder suggest, however, a polygenic
mode of inheritance (reviewed in Duvic et al, 2001; McDonagh
andTazi-Ahnini, 2002). As with many autoimmune diseases with
predisposing HLA haplotypes, there have also been attempts to
¢nd associations with a particular HLA haplotype in AA. These
studies have yielded con£icting results in the case of class I anti-
gens, but increasingly convincing data are now being reported
for associations with certain class II haplotypes. So far, factors that
are associated with susceptibility and/or severity include particu-
lar HLA alleles (e.g., DQB and DR alleles (Welsh et al, 1994; Co-
lombe et al, 1995)). Moreover, interleukin-1 (IL-1) cluster genes
(e.g., IL-1 receptor antagonist) appear strongly associated with
disease severity (Tazi-Ahnini et al, 2002). Finally, there appears to
be some association with chromosome 21, as indicated by the link
with Down’s syndrome and autoimmune polyglandular syn-
drome type I. The mutations implicated here include the autoim-
mune regulator (AIRE) gene on chromosome 21q22.3 and MX1
(Tazi-Ahnini et al, 2000).
The issue of disease associations between AA and other condi-
tions is an important one, not least because it may reveal com-
mon target antigens. Despite a plethora of data, however, the
onlyAA-associated conditions for which there appear su⁄ciently
¢rm data are atopy (De Weert et al, 1984) and Down’s syndrome
(DuVivier and Munro, 1975). AA, when associated with atopy, is
reported to occur earlier in life, have a more severe course and
prognosis, and respond less well to treatment. The incidence of
AA does appear to be increased in patients with Down’s syn-
drome, a condition associated with functional de¢ciencies in T
cell^mediated immune response and abnormalities in serum IgG
levels. Despite textbook assertions to the contrary, careful
review of the literature indicates that incidence of clinically evident
thyroid abnormalities, such as Hashimoto’s chronic lymphocyte
thyroiditis, thyrotoxicosis, exophthalmic goiter, and myxedema,
does not di¡er signi¢cantly in AA patients from that in historical
controls (Korkij et al, 1984). Thus, it is di⁄cult to conclude that
there is an association between thyroid disease and AA. By con-
trast, there is growing evidence of an increase in the prevalence of
diabetes mellitus, especially type I insulin-dependent diabetes, in
relatives of patients with AA but not in the patients themselves
(Wang et al, 1994). These ¢ndings suggest a genetic association be-
tween the two diseases whereby the expression of AA protects
against the development of diabetes mellitus.
Several studies have concluded that the incidence of vitiligo is
increased in AA (Thompson et al, 1974). Here again, however,
large-scale studies have found no signi¢cant association between
AA and vitiligo or a family history of vitiligo (Schallreuter et al,
1994; Tan et al, 2002). Still, vitiligo (also referred to as ‘‘autoim-
mune’’) may yield potential lessons for future directions in AA
research, as it becomes increasingly clear that it exhibits intrinsic
biochemical defects in the entire epidermal melanin unit in skin
(Schallreuter et al, 1994; Schallreuter and Blau,1997). Like vitiligo,
AA is a systemic disease because there is frequent involvement of
tissues other than the HF, including the nails and eyes (Horn and
Odom,1980;Tosti et al, 1985). Thus, the defect may be extrinsic to
HF or, if local, it may target antigens shared with other distant
tissues. It needs to be emphasized nonetheless that the majority
of patients with AA are in good health; it has been estimated that
only 3%^5% have another autoimmune or endocrine disease.
Consequently, the association between AA and other autoim-
mune diseases is more the exception than the rule.
Involvement of a humoral immune response to hair follicles
in alopecia areata Although it has been known for over a
hundred years that dystrophic HF in AA are associated with a
leukocytic in¢ltrate, in 1958 the possibility was formally raised
that AA is an autoimmune disorder (Van Scott, 1958). Only
relatively recently, however, has there been widespread accep-
tance of AA’s immune-mediated basis. AA is associated with a
number of immune abnormalities, some of which are nonselec-
tive while others are speci¢c and point to an immune abnormality
selectively directed to a component of the anagen HF. One
example of a speci¢c abnormality is the abnormal antibody
response directed speci¢cally to HF antigens.
Involvement of the humoral immune response in AA was
¢rst suggested by the observation that abnormal deposits
of immunoglobulin and complement may occur along the
basement membrane zone of the lower half of the HF (Bystryn
et al, 1979). The deposits occasionally extend intercellularly to the
adjacent ORS and are most common at the edge or active border
of lesions. Interestingly, they are also present in uninvolved scalp.
The most frequent immunoreactant deposited is C3 (Igarashi
et al, 1980; Igarashi et al, 1981). It is important to note that
deposits are rarely present along the basement membrane zone
of epidermis overlying involved HF, suggesting that the
immune response is directed to an antigen localized to the HF’s
lower half. That they are present also in uninvolved scalp suggest
that these humoral changes may precede (and thus be involved in
the pathogenesis) rather than merely result from HF injury.
Caution is required in the interpretation of these data, however,
as immunoreactants may also be seen in catagen HF of normal
individuals, where they are associated with thickened and
corrugated hyaline membrane. We recently observed by direct
immuno£uorescence that most dogs with AA also reveal
deposition of IgG in the HF (Tobin et al, in press 2003).We also
saw deposits of IgG on the lower HF glassy membrane/
basal lamina in a majority of subjects and, less frequently, within
the follicular papilla (FP), medulla, ORS, and hair matrix.
Importantly, perifollicular IgG was detected in the cytoplasm of
dermal plasma cells in all but one of the dogs tested.
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It has been reported that some patients with AA have
antibodies to endothelial cells (Nunzi et al, 1980) or pigment
cells (Galbraith et al, 1988). The latter are discussed below in
terms of clues to the identity of the cells targeted by immune
injury in AA.
TARGETING OF HAIR FOLLICLES BYANTIBODIES IN
HUMAN ALOPECIA AREATA
Various organ-speci¢c autoantibodies are said to occur with in-
creased frequency in AA (Friedmann,1981). These associations re-
main for the most part controversial. With the exception of
thyroid autoantibodies, there are as many studies failing to show
an association as there are showing one. Given that the HF is the
central target tissue in AA, it may be expected that there would
be evidence of speci¢c immune responses to this skin appendage.
Thus, about ¢ve years ago we reported for the ¢rst time that anti-
bodies speci¢cally directed to HF do indeed occur in AA (Tobin
et al, 1994a; Tobin et al, 1997c). This observation provided a basis
for rethinking the immune system’s ability to induce an immune
response to HF proteins expressed on or in normal HF. Our con-
temporaneous report of antibodies to HF also in the sera of nor-
mal healthy individuals (Tobin et al, 1994b) was unfortunately
overinterpreted by several in the ¢eld. Speci¢cally, the message
is as follows: Anti-HF antibodies in normal individuals are in-
variably found to be low titer, mostly IgM, and detectable using
the highly sensitive immunoblot assay. Thus, these reactivities are
likely to represent part of the natural autoantibody pool (Cohen
and Cooke, 1986). By contrast, AA-associated anti-HF antibodies
are high-titer IgG and can be detected additionally with the rela-
tively low-sensitivity indirect immuno£uorescence method. This
observation suggests the occurrence of a switch in immunoglo-
bulin isotype from IgM to IgG as a function of the disease pro-
cess, indicative of the maturation of the antibody response to HF
antigens. It may be of note that pathogenic antibodies in autoim-
mune diseases tend to be IgG (Cohen and Cooke, 1986). These
AA-associated reactivities are not part of this natural autoanti-
body pool, but instead are related in some way to pathology.
Thus, a convincing strand of evidence supporting the view that
AA has an autoimmune basis is the observation that antibodies to
HF-speci¢c antigens are much more common and present in
higher levels in patients with AA than in control individuals, in-
cluding those with other types of hair pathology (scarring alope-
cia, demodicosis, etc.).
Hair follicle components targeted by antibodies Many ‘‘AA’’
antibodies are directed speci¢cally to the HF and do not react
with adjacent epidermis or dermis. By contrast, control sera that
react weakly with the HF epithelium also tend to react with the
epidermis and the epithelium of other skin adnexa.
The ‘‘AA’’ antibodies are directed to multiple structures within
anagen HF and also to multiple antigens within each struc-
ture. While this level of heterogeneity may appear somewhat
confounding, it is important to appreciate that, as in other
immune-mediate conditions (e.g., multiple sclerosis), pathology
may involve a shifting of autoreactivity from primary initiating
self-determinants to de¢ned cascades of secondary determinants
that sustain the in£ammatory self-recognition process during
disease progression (Tuohy et al, 1998). Moreover, molecular
mimicry of such determinants by exogenous agents might
readily facilitate spreading of an autoimmune response in gene-
tically susceptible individuals.
The most common HF structure targeted in acute human AA
is the supra-Auber’s matrix/precortex followed by ORS and IRS;
all are keratinocyte-derived structures. Some of these targets are
located in or near proliferating and di¡erentiating areas of the
anagen HF, and thus antibodies to them may have the potential
to disrupt hair di¡erentiation and growth (Tobin et al, 1997b). In
some sera, IgG antibody binding to HF components exhibits
sharp demarcation patterns of reactivityfor example, reactivity
is associated only with the onset of cortex di¡erentiation or to
keratinocytes that will later form the IRS (Tobin et al, 1997b).
By immunoblotting analysis, AA antibodies react strongly with
multiple antigens of 44^60 kDa and 200^220 kDa solubilized
from anagen HF using 6 M urea (Tobin et al, 1994a). The former
molecular weight region contains many keratins, including HF-
speci¢c keratins, whereas the latter equates to the trichohyalin
doublet.
HF antigen targets are highly conserved across species The
last few years have seen signi¢cant progress in the development
and characterization of potentially relevant animal models of AA.
Foremost among these are the aging C3H/HeJ mouse (Sundberg
et al, 1994;Tobin et al, 1997c; McElwee et al, 1998b) and the DEBR
model (McElwee et al, 1996a). Additional progress continues to be
made with the characterization of outbred models (reviewed in
McElwee et al, 1998a), including dogs (Tobin et al, 1998b) and
horses (Tobin et al, 1998a). In all species that we have examined
to date (humans, mice/rats, horses and dogs), antibody reactivity
to HF-speci¢c targets has been detected. Particularly notable was
the observation that similar target components are bound by IgG
antibodies in these species and include the supra-Auber’s matrix/
precortex, ORS, and IRS. In many dogs with AA, for example,
we have detected highly speci¢c reactivities to antigens expressed
by IRS (Tobin et al, 1998b). Moreover, in canine AA, antibodies
can target IRS antigens that are expressed during speci¢c stages
in the di¡erentiation of this anagen-speci¢c HF cell type, such
that only the IRS of the proximal IRS exhibits reactivity. These
¢ndings strongly suggest that autoantigens in AA will include
keratinocyte di¡erentiation^associated proteins.
Use of alopecia areata-associated antibodies to identify hair
follicle antigen targets One of the major hindrances to
progress in AA research is the dearth of knowledge regarding
the identity of the precipitating HF autoantigen. Nevertheless,
immunoblotting studies conducted to date in human, murine,
canine, and equine AA have revealed some intriguing clues. One
of the more common bands of immunoreactive protein expressed
in human HF extracts separates at 44/46 kDa in SDS-PAGE.
When antibody bound to this doublet is eluted from human
AA immunoblots and reprobed with fresh frozen sections of
human haired scalp, antibody reactivity may be detected in the
anagen hair bulb (Tobin and Bystryn, 1996a). This pattern of
reactivity colocalized in the anagen hair bulb (i.e., was restricted
to the precortex) with the 44/46 kDa hair-speci¢c keratin
detected with AE13 monoclonal antibody (Lynch et al, 1986).
More important than this was the subsequent observation that
all AA sera tested, but no control sera, contained IgG that could
immunoprecipitate the 46 kDa hair-speci¢c keratin. By contrast,
AA and control sera equally immunoprecipitated the AE1
reactive soft keratins (Tobin & Bystryn, 1996a).
Furthermore, the occurrence of high-titer IgG that strongly
binds the IRS and reacts with a 200/220 kDa doublet by
immunoblotting in all four species studied, suggested to us that
the IRS-rich protein trichohyalin may be another target
autoantigen. Indeed, we have now shown that whole canine and
equine AA sera, but not control sera, can immunoprecipitate
proteins from a crude HF protein extract that reacts speci¢cally
with AE15, a monoclonal antitrichohyalin antibody. The
involvement of trichohyalin as a target autoantigen in many
cases of AA is of particular note. Trichohyalin is a member of
the intermediate ¢lament-associated protein family and in the
HF is believed to be necessary for correct alignment of keratin
¢laments of the IRS and medulla (O’Guin et al, 1992), It is likely
that defects of IRS di¡erentiation (an anagen-speci¢c event) may
result in defective hair shaft formation.
In further studies, designed to assess the extent of cross-
reactivity of serum IgG in various AA-a¡ected species, we
observed that C3H/HeJ serum IgG reacted with HF-speci¢c
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proteins in human HF extract that were of a similar molecular
weight to those detected when human AA serum was reacted
against murine HF extracts (Tobin et al, 1997c). These ¢ndings
again support the view that AA targets similar HF components
and antigen in all species a¡ected by this disorder.
Cellular targets of the immune response in alopecia
areata The classic bulbitis in AA suggests that an antigen(s)
expressed/located on/in the early-anagen hair bulb is the most
likely immune response target. Three di¡erent cell types in this
structure have been implicated as target cell populations. These
include cortical keratinocytes (Messenger and Bleehen, 1984;
Messenger et al, 1986; Tobin,1997a), melanocytes1 (Messenger and
Bleehen, 1984; Messenger et al, 1986; Tobin et al, 1990a; Bystryn
and Tobin, 1994; Paus et al, 1993; Tobin, 1997a), and endothelial
cells (Nunzi et al, 1980).
Keratinocytes Presently, there is insu⁄cient information to
determine which of these HF cell subpopulations is the primary
target in AA, although clinical, histologic, immunohisto-
chemical, and electron microscopic (EM) evidence indicates that
precortical keratinocytes are damaged. By transmission electron
microscopy, the changes consist of cytoplasmic swelling and
vacuolization, frank cellular necrosis, and increased apoptosis
(Messenger and Bleehen, 1984; Tobin et al, 1991a). Deposits of
granular necrotic debris (commonly with an amorphous
staining pattern) may be present particularly above the basal
Lamina over the upper pole of the follicular papilla. HF
keratinocyte involvement in the pathogenesis of AA, at least at
some stage of the HF pathology, is strongly implicated by the
strong reactivity of AA sera to HF-speci¢c hard acidic keratins
(44/46 kDa). These antigens are expressed preferentially in the
supra-Auber’s region of the anagen hair bulb, the site of active
keratinocyte di¡erentiation into the hair cortex and the IRS.
This view is further supported by the striking reactivity to
trichohyalin (especially in canine and equine AA) and by the
focal weakness in the hair cortex of ‘‘exclamation-mark’’ hair
shafts commonly seen in acute disease (Tobin et al, 1990b).
Melanocytes AA is associated with several clinical pigmentary
anomalies that suggest melanocyte involvement as a target of the
(auto)immune response. There is, for example, relative sparing of
white, depigmented hairs in AA, which may be clinically
evidenced by the phenomenon of rapid ‘‘whitening’’ or ‘‘graying’’
of the hair of a¡ected individuals (Guin et al, 1981). This
phenomenon indicates that HF that are melanocyte containing
and pigment producing are preferentially attacked in AA. Hair
bulb melanocytes are indeed damaged in AA, as evidenced by
the presence of melanophages around the involved hair bulb and
within the cortical matrix (Tobin et al, 1990a; Tobin et al, 1991).
Bulbar melanocytes may be the ¢rst cells in the hair bulb to be
attacked by in¢ltrating immune cells (Peereboom-Wynia et al,
1986).We need to be cautious with this interpretation, however,
as focal melanocyte death may occur in HF with little evidence
of immune cell in¢ltration (Tobin et al, 1991). Further evidence
for selective damage to melanocytes is that regrowing hairs
are often depigmented and that, by transmission electron
microscopy, there is a decreased number of and decreased
functional activity of melanocytes at a stage at which HF have
regained their capacity to make hair (Messenger and Bleehan,
1984). Of critical consideration here is the positive correlation
between melanocyte activity in the hair bulb (which peaks during
an early phase of anagen III/IV) and the stage at which anagen HF
are most vulnerable to the disease insult (Paus et al, 1993).
Although AA is clearly associated with pigmentary anomalies,
there is no evidence that epidermal melanocytes are a¡ected. In
this regard, AA presents us with further evidence that follicular
melanocytes are antigenically distinct from those in the
epidermis (Tobin and Bystryn, 1996b). Melanocytes cultured
from human HF express antigens located cytoplasmically
and occasionally on the cell surface1 (Bystryn and Tobin, 1996
abst). Clearly these observations, which suggest that some AA
patients have antibodies to distinctive pigment cell antigens,
need to be explored further. Melanocytes in locations other than
hair (e.g., in the eye) are also damaged in some patients with AA
(Tosti et al, 1985). It has also been reported that antibodies to
melanoma cells could be detected in AA patients by indirect
immuno£uorescence and western blotting Galbraith et al, 1988).
ROLE OFANTIBODIES TO HAIR FOLLICLE
COMPONENTS IN ALOPECIA AREATA
The pattern and heterogeneity of anti-HF antibodies and their
conserved nature in several a¡ected species are impressive; how-
ever, a basic question remains as to whether anti-HF antibodies
participate in the etiology or pathogenesis of AA. Several obser-
vations suggest that they are not the result of the disease process.
One is that high-titer antibodies are not observed in normal in-
dividuals, despite the release of HF antigens during the normal
HF cycle, or even in scarring alopecias. Another is that in the
C3H/HeJ mouse model of AA the abnormal autoantibody response
to HF is present both in a¡ected mice and, to a lesser degree, in
their as yet clinically una¡ected littermates. This suggests that the
presence of antibodies to HF appears before the onset of hair loss
and so may not be produced as a secondary response to HF damage
in AA.
Recently we examined the anti-HF antibody reactivity pro¢les
of sera taken each month from birth to one year in more than 100
C3H/HeJ mice (unpublished data). Of these mice, 23 developed
AA by month 12 of age. Immunoblot analysis of sera taken from
these AA-a¡ected mice revealed that antibody expression patterns
and titers were modulated during the 12 months and for several
mice increased in expression and intensity before the onset of
clinically detectable hair loss.
Modulation of antibody pro¢le and titer was also seen during
hair regrowth that was induced by topical immunotherapy using
the contact sensitizer diphencyprone (DCP) (Tobin et al, 2002). A
striking reduction was detected in both the titer and the range of
HF components/antigens targeted by anti-HF IgG antibodies in
patients who exhibited complete and sustained hair regrowth
after DCP treatment. As this immunotherapy is associated with
a reduction in the titer/pattern of anti-HF antibodies, this may
hold a key to the identity of the hair follicle antigen targets in
AA. Moreover, the presence/titer of anti-HF antibodies may be a
marker for clinical disease activity and/or an opportunity for
spontaneous regrowth.
Finally, in a recent preliminary study we showed that puri¢ed
IgG from an AA-a¡ected horse could adversely a¡ect hair re-
growth when passively transferred to normal mice (Tobin et al,
1998a). Interestingly, the passively transferred equine ‘‘AA’’ IgG
antibodies localized to the HF but did not induce hair loss per se.
Rather, HF in treated skin were retained in the resting, or
telogen, stage of the hair cyclealthough hair shafts were
shedaround the site of antibody administration. In constrast,
distant HF apparently cycled normally. This study, which needs
to be con¢rmed, should be interpreted in light of an earlier study
that reported the failure of passive transfer of whole serum from
human patients with AA to inhibit hair growth in human scalp
skin grafted onto nude mice (Gilhar et al, 1992).
CONCLUSION
AA may indeed result from an autoimmune response, involving
both T cells and antibodies directed to self-antigens in keratino-
1J-C Bystryn, DJ Tobin. Alopecia areata is associated with antibodies to
hair follicle melanocytes. Journal of Investigative Dermatology 102:4;532, 1994
(abstr).
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cytes and/or melanocytes in hair bulbs, nail, eyes, and so forth.
Inherent in this view is that antigenic properties of keratinocytes
or melanocytes in hair di¡er qualitatively and/or quantitatively
from similar cells in other locations in the epidermis and so may
account for their selective destruction. This is supported by the
expression of unique antigens in HF not detectable in similarly
prepared extracts of epidermis or dermis (Tobin et al, 1994a). AA
preferentially a¡ects hair bulb cells during the surge of mitotic
activity associated with anagen III/IV, phases associated with both
the beginning of di¡erentiation of cortical keratinocytes and the
functional activation of melanocytes. Therefore, it is possible that
the relevant antigens are di¡erentiation antigens (Tobin et al,
1996a) of keratinocytes or melanocytes. It is becoming increas-
ingly clear that AA occurs in all haired mammals and that these
a¡ected animals demonstrate an abnormal HF-speci¢c immune
response. The presence of tissue-speci¢c autoantigens in HF, and
of an abnormal antibody response to HF antigens expressed by
several species with AA, provides the underlying framework ne-
cessary to explain the selective damage to HF that occurs in AA.
Whether anti-HF antibodies have pathogenic potential still needs
to be proved. Nevertheless, even if antibodies to HF are not a
primary agent in the disease, their subsequent production could
further damage or maintain HF pathology. In any case, perhaps
the most valuable contribution that studies of anti-HF antibody
reactivity can make is their help in guiding us to the relevant tar-
get antigens (Girones et al, 2001).
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